Literature DB >> 22246625

Characterization of the promoter and the transcriptional regulation of the lipoxin A4 receptor (FPR2/ALX) gene in human monocytes and macrophages.

Vanessa Waechter1, Mattia Schmid, Magdalena Herova, Angelika Weber, Viola Günther, Jacqueline Marti-Jaun, Sophia Wüst, Marian Rösinger, Claudio Gemperle, Martin Hersberger.   

Abstract

The lipoxin A4 receptor FPR2/ALX plays an important part in host defense and inflammation. The receptor binds structurally diverse agonistic ligands, which mainly regulate chemotaxis and activation of leukocytes. However, little is known about the promoter region of the FPR2/ALX gene and its transcriptional regulation in leukocytes. We identified two TATA-less promoter regions, separated by 224 bp, that drive the expression of FPR2/ALX in macrophages. Both promoter regions increased transcription in a reporter assay, and the basal transcription factors OCT1 and SP1 were shown to bind the first and the second promoter, respectively, and to transactivate transcription. Although monocytes expressed high levels of FPR2/ALX mRNA from the second promoter region, differentiation into macrophages abrogated FPR2/ALX expression. Stimulation of macrophages with a set of cytokines revealed that only IFN-γ and LPS increased FPR2/ALX expression from the first promoter to levels similar to those detected in monocytes. The upregulation by IFN-γ is in part mediated by the interaction of IFN regulatory factor 1 with an IFN-responsive sequence element transcription factor binding site located in the first promoter region of the FPR2/ALX gene. However, this upregulation on the mRNA level did not translate into FPR2/ALX protein expression in macrophages owing to reduced translation of the longer mRNA from the first promoter. In contrast, FPR2/ALX mRNA transcribed from the second promoter was translated into surface expression of FPR2/ALX in monocytes. These data support a model in which FPR2/ALX plays a role in chemotaxis and activation of monocytes; however, they also suggest that its function in resident tissue macrophages is limited.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22246625     DOI: 10.4049/jimmunol.1101788

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  SAA drives proinflammatory heterotypic macrophage differentiation in the lung via CSF-1R-dependent signaling.

Authors:  Desiree Anthony; Jonathan L McQualter; Maria Bishara; Ee X Lim; Selcuk Yatmaz; Huei Jiunn Seow; Michelle Hansen; Michelle Thompson; John A Hamilton; Louis B Irving; Bruce D Levy; Ross Vlahos; Gary P Anderson; Steven Bozinovski
Journal:  FASEB J       Date:  2014-05-20       Impact factor: 5.191

Review 2.  New Advances in Targeting the Resolution of Inflammation: Implications for Specialized Pro-Resolving Mediator GPCR Drug Discovery.

Authors:  Julia Park; Christopher J Langmead; Darren M Riddy
Journal:  ACS Pharmacol Transl Sci       Date:  2020-01-20

3.  Crosstalk Between RPE Cells and Choroidal Endothelial Cells via the ANXA1/FPR2/SHP2/NLRP3 Inflammasome/Pyroptosis Axis Promotes Choroidal Neovascularization.

Authors:  Manhui Zhu; Ying Wang; Linling Zhu; Shu Du; Zhenzhen Wang; Yuting Zhang; Yang Guo; Yuanyuan Tu; E Song
Journal:  Inflammation       Date:  2021-10-01       Impact factor: 4.092

Review 4.  The role of lipoxin A4 in endometrial biology and endometriosis.

Authors:  G O Canny; B A Lessey
Journal:  Mucosal Immunol       Date:  2013-03-13       Impact factor: 7.313

5.  Lipoxin A₄ modulates adaptive immunity by decreasing memory B-cell responses via an ALX/FPR2-dependent mechanism.

Authors:  Sesquile Ramon; Simona Bancos; Charles N Serhan; Richard P Phipps
Journal:  Eur J Immunol       Date:  2014-02       Impact factor: 5.532

6.  Resolution of inflammation is altered in Alzheimer's disease.

Authors:  Xiuzhe Wang; Mingqin Zhu; Erik Hjorth; Veronica Cortés-Toro; Helga Eyjolfsdottir; Caroline Graff; Inger Nennesmo; Jan Palmblad; Maria Eriksdotter; Kumar Sambamurti; Jonathan M Fitzgerald; Charles N Serhan; Ann-Charlotte Granholm; Marianne Schultzberg
Journal:  Alzheimers Dement       Date:  2014-02-12       Impact factor: 21.566

7.  Deficiency of formyl peptide receptor 1 and 2 is associated with increased inflammation and enhanced liver injury after LPS-stimulation.

Authors:  Arne Giebeler; Konrad L Streetz; Oliver Soehnlein; Ulf Neumann; Ji Ming Wang; Lars-Ove Brandenburg
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240

8.  Differentiation of human monocytes and derived subsets of macrophages and dendritic cells by the HLDA10 monoclonal antibody panel.

Authors:  Anna Ohradanova-Repic; Christian Machacek; Michael B Fischer; Hannes Stockinger
Journal:  Clin Transl Immunology       Date:  2016-01-08

9.  Transcription Factor SP2 Enhanced the Expression of Cd14 in Colitis-Susceptible C3H/HeJBir.

Authors:  Nils-Holger Zschemisch; Inga Brüsch; Anne-Sophie Hambusch; André Bleich
Journal:  PLoS One       Date:  2016-05-18       Impact factor: 3.240

Review 10.  A review of non-prostanoid, eicosanoid receptors: expression, characterization, regulation, and mechanism of action.

Authors:  Roger G Biringer
Journal:  J Cell Commun Signal       Date:  2021-06-26       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.